Hahn's Priorities For US FDA Eschew Hot-Button Issues, Focus on Traditional Themes

 
• By Derrick Gingery

Promoting innovation, expansion of data use, and patient and consumer empowerment will affect agency work going forward, the FDA Commissioner said in his first all-staff address. Absent from his all-hands memo was drug pricing, opioids, or any other potentially political themes.  

Commissioner Stephen Hahn addresses FDA staff for the first time on 30 January 2020; his accompanying all-hands memo did not mention controversial issues like drug pricing or opioids. • Source: FDA

More from US FDA

More from Agency Leadership